Merit Medical director receives 3,457 RSU award

Ward Scott R. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ward Scott R. reported acquisition or exercise transactions in this Form 4 filing.

Merit Medical Systems director Scott R. Ward received an equity award of 3,457 shares. The Form 4 reports a grant of 3,457 restricted stock units under the company’s 2026 Equity Incentive Plan at no purchase price. These RSUs will vest on May 3, 2027, subject to his continued service with the company through the vesting date. Following this award, his reported direct holdings from this grant total 3,457 shares of common stock-equivalent units, reflecting routine, compensation-related equity rather than an open-market purchase or sale.

Insights

Equity compensation analyst

Routine RSU grant to a director with time-based vesting.

The filing shows director Scott R. Ward receiving 3,457 restricted stock units as a stock-based compensation award under the 2026 Equity Incentive Plan. The grant carries a zero dollar exercise or purchase price, consistent with standard RSU structures.

The RSUs vest in a single tranche on May 3, 2027, contingent on continued service. This is a time-based award with no performance conditions mentioned, so the primary risk is tenure rather than business metrics.

With 3,457 shares reported as held after the transaction and no derivative positions listed, this appears to be a straightforward, routine compensation grant rather than a directional market trade, and on its own is typically viewed as neutral for the broader investment case.

Insider Trade Summary

Grant/Award: 3,457 shares

Grant/Award 1 txn

Insider Ward Scott R.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, No Par Value	3,457	$0.00	$0.00

Holdings After Transaction: Common Stock, No Par Value — 3,457 shares (Direct)

Footnotes (1)

1. F1. The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

Key Figures

RSU grant size: 3,457 units Grant price: $0.00 per unit Vesting date: May 3, 2027 +1 more

4 metrics

RSU grant size 3,457 units Restricted stock units granted to director

Grant price $0.00 per unit RSU award under equity plan

Vesting date May 3, 2027 RSUs vest if service continues to this date

Shares after transaction 3,457 shares Total reported direct holdings from this grant

Key Terms

restricted stock units (RSUs), 2026 Equity Incentive Plan, vesting, continued service

4 terms

restricted stock units (RSUs) financial

"The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs)"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

2026 Equity Incentive Plan financial

"under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan"

vesting financial

"The RSUs granted to the reporting person will vest on May 3, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continued service financial

"Vesting of the RSUs is subject to continued service to the issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Merit Medical Systems (MMSI) director Scott R. Ward receive in this Form 4?

Scott R. Ward received an equity grant of 3,457 restricted stock units in Merit Medical Systems. These RSUs represent share-based compensation rather than an open-market stock purchase or sale, increasing his direct equity-linked holdings by 3,457 units.

When do Scott R. Ward’s 3,457 RSUs in Merit Medical (MMSI) vest?

The 3,457 restricted stock units granted to Scott R. Ward vest on May 3, 2027. Vesting is contingent on his continued service with Merit Medical Systems through that date, meaning the units only become shares if he remains in his role.

Was cash paid for the 3,457-share award reported in MMSI’s Form 4?

No cash was paid for this award; the Form 4 lists a $0.00 per-share price for the 3,457 units. This indicates a stock-based compensation grant, typical for director equity awards, rather than a market transaction involving cash outlay.

How many Merit Medical (MMSI) shares does Scott R. Ward hold after this RSU grant?

After the reported grant, Scott R. Ward’s holdings from this award total 3,457 shares-equivalent according to the Form 4. These reflect the RSUs granted, which will convert into common stock upon vesting if service conditions are satisfied.

What plan governs the 3,457 RSU grant to the Merit Medical (MMSI) director?

The 3,457 restricted stock units were granted under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. This plan authorizes equity-based compensation awards, aligning director incentives with shareholder interests through stock-denominated grants instead of cash-only compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 06:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ward Scott R.

(Last) (First) (Middle)

1600 W MERIT PARKWAY

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	05/18/2026		A		3,457(1)	A	$0	3,457	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

	/s/ Brian G. Lloyd, Attorney-in-Fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)